Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Sterifre Medical

Request full access

Developing a proprietary low cost “plug-and-play technology platform

Kirkland, United StatesFounded 2016Health Tech & Medtech

About Sterifre Medical

Sterifre Medical Inc., founded in 2016 and based in Kirkland, Washington, is a medical technology company addressing the critical need for rapid, point-of-care disinfection within healthcare facilities. The company was established to combat the high rates of hospital-acquired infections (HAIs), which affect a significant number of patients annually. Spearheaded by CEO Richard Shea, a former executive at Stericycle and CEO of Olympus Respiratory America, the leadership team possesses deep experience in infection control and medical devices. The company's strategic decision to outsource engineering and manufacturing reflects a focused business model centered on sales, marketing, and customer service.

Sterifre's core offering is the Aura™ system, an automated, compact disinfection device designed for non-critical medical equipment and other hard-surface items frequently used in hospitals and clinics. This patented technology utilizes a novel combination of hydrogen peroxide and activated oxygen (cold plasma ozone) at room temperature, which allows it to disinfect a wide array of sensitive materials, including plastics, electronics, and metals, without causing the damage often associated with chemical wipes and sprays. The device is engineered to be a simple, one-touch system that automates previously manual disinfection processes, thereby enhancing compliance with safety protocols and improving workflow for healthcare staff. The U.S. Environmental Protection Agency (EPA) granted Sterifre registration for the Aura system in late 2021, a key milestone enabling its commercial deployment.

The company targets the U.S. Acute Care Market, positioning Aura as a solution to reduce operational costs and environmental impact. One consumable cartridge for the Aura device can replace approximately 44 canisters of disposable disinfectant wipes, reducing waste and storage needs. Sterifre employs a subscription-based business model, which is distinctive for medical hardware. This monthly fee covers the device, maintenance, training, and consumables like the hydrogen peroxide cartridges and indicator strips, offering hospitals a predictable operating expense without a large capital outlay. The firm has successfully raised significant capital to fund its commercialization efforts, securing $12 million in a Series A round in 2017, followed by an $8 million Series B round in 2019 and a subsequent $3.08 million in 2023, bringing its total funding to over $20 million.

Source: Dealroom company data

At a glance

Status
Operational
Employees
3
Open positions
None listed
Dealroom signal
62.8/100
Industry
Health
Sub-industry
Medical Devices
Sector
Infections and Infectious Diseases, Spinout, Hospital, DT and LS, science-based
Technology
Deep Tech
Client focus
B2B

Funding history

5 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
EARLY VC✓Equity / VC May 2023 $3.1M $40M Undisclosed ↗
SERIES B✓Equity / VC Jul 2019 $8M $32M Undisclosed —
Showing the latest 2 of 5 recorded eventsBook a demo for the full funding history →

Growth signals

Sterifre Medical website traffic

Latest recorded traffic for Sterifre Medical is 140 monthly website visits, down 73.6% over the last three months. Sterifre Medical's team grew 0% over the past year.

Latest monthly visits140 3-month web change-73.6% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Sterifre Medical in the Kirkland ecosystem

Live from Dealroom

The Sterifre Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • FuzeHub

Other known investors2 additional known investors

  • Cornell University
  • Center for Life Science Ventures
Team profiled 3 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Sterifre Medical on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Sterifre Medical’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.